As part of the International Day of Women and Girls in Science, the BBRC is taking part for the second consecutive year in this initiative, which aims to highlight the strategic role of women in science and technology.
The project is one of 13 selected in this year’s edition, which aims to support emerging research projects in the fields of health and sustainability in Barcelona.
The €76,600 grant will enable Dr Soldevila to develop her research line within the Clinical Research and Risk Factors for Neurodegenerative Diseases Group at the BBRC.
The book is leading reference on biomarkers shaping diagnosis, prognosis, and therapy development in Alzheimer’s disease and related dementias.
The GLYMPH-AD project, led by Dr Gonzalo Sánchez Benavides, will investigate the relationship between nocturnal blood pressure, the glymphatic system, loss of smell and the risk of developing Alzheimer’s disease.
Dr. Gemma Salvadó presented an oral communication at the 18th edition of the conference dedicated to clinical trials on Alzheimer's disease.
The Barcelonaβeta Brain Research Center (BBRC) and the Pasqual Maragall Foundation join DORA and CoARA, committing to a fairer and more inclusive research assessment that values quality and impact over traditional metrics.
Anna Soteras has been appointed Director of BBRC’s Clinical Operations Facility, where she will lead the co-ordination and delivery of the centre’s clinical studies.
These findings reinforce the robustness of current CSF tools for early detection while encouraging sex-aware interpretation when tracking disease biology over time